Skip to main content

Table 2 Subgroup analysis of DFS

From: Association between apolipoprotein E ε4 status and the risk of Alzheimer’s disease: a meta-analysis

Endpoint

Factor

No. of studies

Heterogeneity test (I2, P)

Effect model

HR

95%CI of HR

Conclusion

DFS

region

      
 

Asian

11

92.7,0.000

random

2.18

1.47,3.22

significant

 

Europen

12

90.9,0.000

random

1.94

1.33,2.83

significant

 

USA

7

75.4, 0.000

random

2.00

1.40, 2.88

significant

 

study design

      
 

P

22

94.3,0.000

random

2.02

1.46,2.78

significant

 

R

8

83.1,0.000

random

2.13

1.54,2.93

significant

 

Cutoff method

      
 

ROC

4

0.0,0.661

fixed

3.07

2.26,4.16

significant

 

Others

26

93.9,0.000

random

1.95

1.49,2.54

significant

  1. DFS = disease-free survival, HR = hazard ratio, CI = confidence interval, P prospective, R retrospective, ROC = receiver operating characteristic